BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 4457445)

  • 1. [New CPK mass screening test in the early diagnosis of muscular diseases].
    Beckmann R; Scheuerbrandt G; Antonik A; Antonik S
    Fortschr Med; 1974 Nov; 92(33):1348-54. PubMed ID: 4457445
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis of preclinical Duchenne's muscular dystrophy in the newborn using the CK screening test].
    Beckmann R; Scheuerbrandt G; Antonik A
    Monatsschr Kinderheilkd (1902); 1976 Sep; 129(9):658-9. PubMed ID: 979985
    [No Abstract]   [Full Text] [Related]  

  • 3. Newborn screening for Duchenne muscular dystrophy.
    Zellweger H; Antonik A
    Pediatrics; 1975 Jan; 55(1):30-4. PubMed ID: 1110862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and its problems in neuromuscular diseases, with special reference to biochemical examinations--enzymatic diagnosis].
    Furukawa T
    Nihon Rinsho; 1969 Jan; 27(1):96-102. PubMed ID: 4890036
    [No Abstract]   [Full Text] [Related]  

  • 5. [Enzyme diagnosis of muscular diseases].
    Somer H; Konttinen A
    Duodecim; 1972; 88(23):1498-506. PubMed ID: 4640852
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of preclinical Duchenne muscular dystrophy and its female carriers.
    Beckmann R
    Isr J Med Sci; 1977 Feb; 13(2):102-6. PubMed ID: 863671
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum pyruvate kinase (PK) in the diagnosis of neuromuscular diseases].
    Chen Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Dec; 18(6):338-41. PubMed ID: 3836824
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of the determination of cretaine phosphokinase activity (CPK) in certain diseases of the muscles.
    Hetnarska L
    Pol Med J; 1968; 7(3):742-6. PubMed ID: 5669716
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of the prednisolone test in myopathy diagnosis].
    Jörg J; Gerhard H
    Fortschr Neurol Psychiatr; 1984 Jan; 52(1):11-4. PubMed ID: 6698478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creatine phosphokinase of the blood serum in muscular disorders.
    Sercl M; Kovarík J; Tichý K; Kyral V; Lichý J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1973; 16(3):129-45. PubMed ID: 4531711
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum creatine phosphokinase in various muscular diseases seen in the field of orthopedic surgery].
    Iwamoto A
    Igaku Kenkyu; 1969 May; 39(2):108-21. PubMed ID: 5389323
    [No Abstract]   [Full Text] [Related]  

  • 12. [Differential diagnosis of Becker and Duchenne muscular dystrophy].
    Alvarez Leal M; Hernández Sifuentes PM; Pérez-Zuno JA
    Gac Med Mex; 1994; 130(6):454-8. PubMed ID: 7557060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enzyme diagnosis in bone and muscular diseases].
    Locher M
    Z Allgemeinmed; 1969 Aug; 45(22):1031-6. PubMed ID: 5809169
    [No Abstract]   [Full Text] [Related]  

  • 14. Sex linked muscular dystrophies: severe and benign variety.
    Desai AD; Deshpande DH; Banerji AP; Jayam AV; Raju TN
    Neurol India; 1972 Dec; 20(4):163-89. PubMed ID: 4662748
    [No Abstract]   [Full Text] [Related]  

  • 15. [The serum-creatine phosphokinase (CPK) activity in amyotrophic lateral sclerosis (ALS) and other neurogenous muscular atrophies with regard to differential diagnostic aspects].
    Koufen H; Consbruch U
    Nervenarzt; 1970 Dec; 41(12):599-603. PubMed ID: 4924032
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the activity of blood serum enzymes in relatives of children with myopathy].
    Grinio LP
    Vopr Med Khim; 1966; 12(6):600-3. PubMed ID: 6000902
    [No Abstract]   [Full Text] [Related]  

  • 17. Muscular dystrophy: clinical, electrical, histological and biochemical study.
    Desai AD; Braganca BM; Divekar AY; Bubelis I; Deshpande DH; Rebello MD
    Neurol India; 1966; 14(4):167-73. PubMed ID: 5977713
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic counselling in neuromuscular diseases in Western Australia.
    Hurse PV; Kakulas BA
    Proc Aust Assoc Neurol; 1974; 11():145-53. PubMed ID: 4469625
    [No Abstract]   [Full Text] [Related]  

  • 19. [Identification of the carrier state in the severe recessive X-linked muscular dystrophy (Duchenne type). I. Assay of activated serum creatine kinase activity in serum (author's transl)].
    Rotthauwe HW; Kowalewski S
    Z Kinderheilkd; 1973 Nov; 115(4):333-42. PubMed ID: 4591596
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy].
    Lujf A; Sluga E; Moser K
    Wien Klin Wochenschr; 1971 Feb; 83(7):109-13. PubMed ID: 5547427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.